閆凌

[摘要] 目的 對比分析傳統切開掛線術與切開曠置術聯合墊壓法治療高位復雜肛瘺的效果。方法 選取該院收治的高位復雜肛瘺患者90例,將其隨機平均分為研究組與對照組。對照組采取傳統切開掛線術治療,研究組采取切開曠置術聯合墊壓法治療。結果 研究組術后當天、術后7 d時發熱、滲出、疼痛的評分顯著低于對照組(P<0.05);兩組均未見肛門狹窄及不全性肛門失禁出現;兩組復發率對比差異無統計學意義(P>0.05)。結論 相較于傳統切開掛線術,切開曠置術聯合墊壓法可以有效改善高位復雜肛瘺患者術后發熱、滲出等情況,降低疼痛閾值,減輕患者的痛苦,適于臨床應用與推廣。
[關鍵詞] 傳統切開掛線術;切開曠置術;墊壓法;高位復雜肛瘺
[中圖分類號] R56 [文獻標識碼] A [文章編號] 1674-0742(2015)05(a)-0008-02
Traditional Incision and Thread and Joint Surgery Incision Exclusion Pad Complex High-pressure Treatment of Anal Fistula Control Analysis
YAN Ling
Second Department of General Surgery,the Regional Hospital of Anyang City,Henan Province,455000 China
[Abstract] Objective To compare the traditional incision and thread and cut exclusion operation combined pad-pressure high complex anal fistula treatment effect. Methods I received high complex anal fistula hospital 90 patients were randomly divided into study group and the control group. The control group received traditional incision line treatment, the study group to take joint surgery incision exclusion pad-pressure treatment. Results The study group was the day after surgery 7d fever, oozing, pain scores were significantly lower than the control group (P<0.05);the two groups showed no anal stenosis and insufficiency of incontinence occurs; relapse rate comparison groups no significant difference (P>0.05). Conclusion The traditional incision and thread, cut the exclusion operation combined pad pressure method can effectively improve the postoperative fever complex high anal fistula, exudation, etc., reduce the pain threshold, compared to alleviate the suffering of patients, suitable for clinical application and promotion.
[Key words] Traditional incision and thread; Incision surgery exclusion; Pad pressure method; High complex anal fistula
目前,高位復雜肛瘺是肛腸科中公認難題,手術是其治療的唯一手段。雖然傳給切開掛線治療高位復雜肛瘺可以收取到一定的療程,但具有愈合時間長、痛苦大、肛門失禁等缺點,無法保障預后質量。為對比傳統切開掛線術與切開曠置術聯合墊壓法治療高位復雜肛瘺的效果,2012年4月—2014年4月期間該院對45例高位復雜性肛瘺患者實施了切開曠置術聯合墊壓法治療,并與傳統切開掛線術對比,為完善臨床治療方案提供有效的參考,現報道如下。
1 資料與方法
1.1 一般資料
隨機選擇該院收治的高位復雜肛瘺患者90例,所有患者均經衡水會議制定的肛瘺診斷標準[1]確診,且對該次研究知情并簽署知情同意書。排除標準:炎性腸病性肛瘺;合并腫瘤;合并心、腎、肝及造血系統等原發性疾病;……